Cardiac I-MIBG Normal Uptake Values Are Population-specific: Results from a Cohort of Controls over 60 Years of Age

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2019 Sep 19

PMID 31529384

Citations 6

Authors

G Roberts

J J Lloyd

J P M Kane

R Durcan

S Lawley

K Howe

G S Petrides

J T OBrien

A J Thomas

Affiliations

Soon will be listed here.

Abstract

Purpose: Cardiac I-MIBG image interpretation is affected by population differences and technical factors. We recruited older adults without cognitive decline and compared their cardiac MIBG uptake with results from the literature.

Methods: Phantom calibration confirmed that cardiac uptake results from Japan could be applied to our center. We recruited 31 controls, 17 individuals with dementia with Lewy bodies (DLB) and 15 with Alzheimer's disease (AD). Images were acquired 20 minutes and four hours after injection using Siemens cameras with medium-energy low-penetration (MELP) collimators. Local normal heart-to-mediastinum (HMR) ratios were compared to Japanese results.

Results: Siemens gamma cameras with MELP collimators should give HMRs very close to the calibrated values used in Japan. However, our cut-offs with controls were lower at 2.07 for early and 1.86 for delayed images. Applying our lower cut-off to the dementia patients may increase the specificity of cardiac MIBG imaging for DLB diagnosis in a UK population without reducing sensitivity.

Conclusions: Our local HMR cut-off values are lower than in Japan, higher than in a large US study but similar to those found in another UK center. UK centers using other cameras and collimators may need to use different cut-offs to apply our results.

Citing Articles

Longitudinal changes in cardiac mIBG scintigraphy in mild cognitive impairment with Lewy bodies.

Greenfinch G, Hamilton C, Donaghy P, Firbank M, Barnett N, Allan L BJPsych Open. 2024; 10(6):e223.

PMID: 39635755 PMC: 11698149. DOI: 10.1192/bjo.2024.766.

Sympathetic I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging.

Nakajima K, Matsumura T, Komatsu J, Wakabayashi H, Ono K, Kinuya S Ann Nucl Med. 2024; 38(10):814-824.

PMID: 38869809 PMC: 11401792. DOI: 10.1007/s12149-024-01950-4.

Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio.

Okuda K, Nakajima K, Kitamura C, Ljungberg M, Hosoya T, Kirihara Y J Nucl Cardiol. 2023; 30(4):1630-1641.

PMID: 36740650 PMC: 10372132. DOI: 10.1007/s12350-023-03198-3.

A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease.

Thomas A, Hamilton C, Heslegrave A, Barker S, Durcan R, Lawley S Mov Disord. 2022; 37(7):1495-1504.

PMID: 35318733 PMC: 9540809. DOI: 10.1002/mds.28994.

Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.

Roberts G, Durcan R, Donaghy P, Lawley S, Ciafone J, Hamilton C Neurology. 2021; 96(23):e2801-e2811.

PMID: 33883238 PMC: 8205462. DOI: 10.1212/WNL.0000000000012060.

References

Kane J, Surendranathan A, Bentley A, Barker S, Taylor J, Thomas A . Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018; 10(1):19. PMC: 5815202. DOI: 10.1186/s13195-018-0350-6. View

Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T . Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol. 2009; 16(2):212-7. DOI: 10.1111/j.1468-1331.2008.02388.x. View

Lee D, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas A . Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2012; 28(2):135-41. DOI: 10.1002/gps.3799. View

Galvin J, Duda J, Kaufer D, Lippa C, Taylor A, Zarit S . Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. 2010; 16(6):388-92. PMC: 2916037. DOI: 10.1016/j.parkreldis.2010.03.007. View

McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

Donaghy P, McKeith I . The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther. 2014; 6(4):46. PMC: 4255387. DOI: 10.1186/alzrt274. View

Schneider J, Arvanitakis Z, Yu L, Boyle P, Leurgans S, Bennett D . Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012; 135(Pt 10):3005-14. PMC: 3470712. DOI: 10.1093/brain/aws234. View

Roberts G, Kane J, Lloyd J, Petrides G, Howe K, OBrien J . A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies. Nucl Med Commun. 2019; 40(7):734-743. DOI: 10.1097/MNM.0000000000001024. View

Kane J, Roberts G, Petrides G, Lloyd J, OBrien J, Thomas A . I-MIBG scintigraphy utility and cut-off value in a clinically representative dementia cohort. Parkinsonism Relat Disord. 2019; 62:79-84. DOI: 10.1016/j.parkreldis.2019.01.024. View

10.

Nakajima K, Verschure D, Okuda K, Verberne H . Standardization of I--iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications. Clin Transl Imaging. 2017; 5(3):255-263. PMC: 5437131. DOI: 10.1007/s40336-017-0230-2. View

11.

Verschure D, Poel E, Nakajima K, Okuda K, van Eck-Smit B, Somsen G . A European myocardial I-mIBG cross-calibration phantom study. J Nucl Cardiol. 2017; 25(4):1191-1197. PMC: 6133137. DOI: 10.1007/s12350-017-0782-6. View

12.

Slomka P, Mehta P, Germano G, Berman D . Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all. J Nucl Cardiol. 2014; 21(5):979-83. DOI: 10.1007/s12350-014-9943-z. View

13.

Klene C, Jungen C, Okuda K, Kobayashi Y, Helberg A, Mester J . Influence of ROI definition on the heart-to-mediastinum ratio in planar I-MIBG imaging. J Nucl Cardiol. 2016; 25(1):208-216. DOI: 10.1007/s12350-016-0708-8. View

14.

Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M . Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010; 37(9):1802-12. DOI: 10.1007/s00259-010-1491-4. View

15.

Jacobson A, Senior R, Cerqueira M, Wong N, Thomas G, Lopez V . Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. DOI: 10.1016/j.jacc.2010.01.014. View

16.

Nakajima K, Okuda K, Yoshimura M, Matsuo S, Wakabayashi H, Imanishi Y . Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol. 2014; 21(5):970-8. PMC: 4167440. DOI: 10.1007/s12350-014-9916-2. View

17.

Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M . Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2011; 39(1):113-9. DOI: 10.1007/s00259-011-1963-1. View

18.

Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H . Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One. 2015; 10(3):e0120540. PMC: 4368705. DOI: 10.1371/journal.pone.0120540. View

19.

Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T . I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry. 2018; 89(11):1167-1173. DOI: 10.1136/jnnp-2017-317398. View

20.

Waqar F, Gerson M . Cardiac sympathetic imaging in the diagnosis of cardiac autonomic neuropathy in pre-diabetes. J Nucl Cardiol. 2015; 22(6):1269-72. DOI: 10.1007/s12350-015-0082-y. View